Recently, it was found that Lgr5+ cells can differentially contribute to tumor progression and authors showed higher Lgr5+ frequency in mutant TP5344, thus opening the possibility that Lgr5+ ISCs dependence in cancer is linked to TP53 status. The gene discussed is TP53; the disease is neoplasm.